Online Resources

Links to Helpful Menopause Related Web Sites:

American Association of Clinical Endocrinologists

According to the American Association of Clinical Endocrinologists, this web site for U.S. endocrinologists provides clinical guidelines for the prevention and treatment of osteoporosis and more.

The American College of Obstetricians and Gynecologists

The American College of Obstetricians and Gynecologists (ACOG) states that is a membership organization of obstetrician/gynecologists dedicated to the advancement of women's health through education, advocacy, practice and research.

The Hormone Foundation

According to The Hormone Foundation, this non-profit organization works to educate the public about the role of hormones in health and disease.

International Menopause Society

As stated by the International Menopause Society, their aim is to promote knowledge, study and research on all aspects of aging in men and women; to organize, prepare, hold and participate in international meetings and congresses on this subject; and to encourage the interchange of research plans and experience between individual members.

Back to Top

National Association of Nurse Practitioners in Women's Health (NPWH)

NPWH states their mission is to assure the provision of quality health care to women of all ages by nurse practitioners.

National Institute on Aging

According to the National Institute on Aging (NIA), it is one of the 25 institutes and centers of the National Institutes of Health, and leads a broad scientific effort to understand the nature of aging and to extend the healthy, active years of life.

National Institutes of Health (NIH)

The NIH states its mission is to uncover new knowledge that will lead to better health for everyone. NIH works toward that mission by conducting research in its own laboratories; supporting the research of non-Federal scientists in universities, medical schools, hospitals and research institutions throughout the country and abroad; helping in the training of research investigators; and fostering communication of medical information.

National Institutes of Health – Osteoporosis and Related Bone Diseases National Resource Center

The NIH ORBD~NRC’s states its mission is to provide patients, health professionals and the public with an important link to resources and information on metabolic bone diseases, including osteoporosis, Paget's disease of the bone, osteogenesis imperfecta and hyperparathyroidism.

Back to Top

National Osteoporosis Foundation

According to the National Osteoporosis Foundation (NOF), it is the nation's leading resource for people seeking up-to-date, medically sound information on the causes, prevention, detection and treatment of osteoporosis.

National Women's Health Information Center

As stated by the National Women's Health Information Center, it is sponsored by the U.S. Public Health Service's Office on Women's Health, it is a one-step gateway for women's health services.

National Women's Health Resource Center

This U.S. federal government clearinghouse for women's health states its data provides a variety of useful information on various topics including menopause.

North American Menopause Society

According to the North American Menopause Society, this The leading scientific nonprofit organization’s web site is devoted to promoting women's health during midlife and beyond through understanding of menopause.

Back to Top

North American Menopause Society Healthfinder

As stated by the North American Menopause Society Healthfinder, this site by the U.S. government's Department of Health and Human Services links to consumer health and human services information resources produced by the federal government and its partner organizations.

The Office of Women's Health

According to the Office of Women's Health, it is the FDA's leading resource for women's health information, the Office of Women's Health (OWH) serves as a champion for women's health both within and outside the agency.

Women’s Health Initiative

Women's Health Initiative Study Findings.

Back to Top

Estrogens and progestins should not be used for the prevention of cardiovascular disease or dementia.

The Women’s Health Initiative (WHI) study reported increased risks of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women (50 to 79 years of age) during 5 years of treatment with oral conjugated estrogens (CE 0.625 mg) combined with medroxyprogesterone acetate (MPA 2.5 mg) relative to placebo.

The Women’s Health Initiative Memory Study (WHIMS), a substudy of WHI, reported increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 4 years of treatment with oral conjugated estrogens plus MPA relative to placebo. It is unknown whether this finding applies to younger postmenopausal women.

Other doses of oral conjugated estrogens with MPA, and other combinations and dosage forms of estrogens and progestins were not studied in the WHI clinical trials and, in the absence of comparable data, these risks should be assumed to be similar. Because of these risks, estrogens with progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.

Estrogens and estrogens/progestins combined should not be used in women with undiagnosed abnormal genital bleeding; known, suspected, or history of breast cancer; known or suspected estrogen-dependent neoplasia; active deep vein thrombosis, pulmonary embolism, or history of these conditions; active or recent arterial thromboembolic disease; liver dysfunction or disease; or known or suspected pregnancy.

In clinical trials with CombiPatch, the most common side effects were breast pain, dysmenorrhea, and headache.

CombiPatch is indicated for women with an intact uterus for the treatment of moderate to severe vasomotor symptoms associated with menopause, and moderate to severe symptoms of vulvar and vaginal atrophy associated with menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered.



The information contained within this web site is appropriate for U.S. healthcare professionals only.

Available by prescription only.

Copyright © 2006 Novogyne Pharmaceuticals.. All rights reserved.